Gene · 5313
Papers2,223
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,223
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| T3 and glucose increase expression of phosphoenolpyruvate carboxykinase (PCK1) leading to increased β-cell proliferation. | Mol Metab | 2022 | 36455788 | PubTator, text mining | PubMed |
| A rare mutation (p.F149del) of the NT5C3A gene is associated with pyrimidine 5'-nucleotidase deficiency. | Cell Mol Biol Lett | 2022 | 36434495 | PubTator, text mining | PubMed |
| Tissue-Specific Human Extracellular Matrix Scaffolds Promote Pancreatic Tumour Progression and Chemotherapy Resistance. | Cells | 2022 | 36429078 | PubTator, text mining | PubMed |
| The emerging role of the microbiome in Alzheimer's disease. | Int Rev Neurobiol | 2022 | 36427953 | PubTator, text mining | PubMed |
| Investigation of key signaling pathways and appropriate diagnostic biomarkers selection between non-invasive to invasive stages in pancreatic cancer: a computational observation. | J Med Life | 2022 | 36415513 | PubTator, text mining | PubMed |
| BRAF activation by metabolic stress promotes glycolysis sensitizing NRASQ61-mutated melanomas to targeted therapy. | Nat Commun | 2022 | 36402789 | PubTator, text mining | PubMed |
| Influence of Anodizing Parameters on Tribological Properties and Wettability of Al2O3 Layers Produced on the EN AW-5251 Aluminum Alloy. | Materials (Basel) | 2022 | 36363325 | PubTator, text mining | PubMed |
| Druggable Metabolic Vulnerabilities Are Exposed and Masked during Progression to Castration Resistant Prostate Cancer. | Biomolecules | 2022 | 36358940 | PubTator, text mining | PubMed |
| Luteolin, a Potent Anticancer Compound: From Chemistry to Cellular Interactions and Synergetic Perspectives. | Cancers (Basel) | 2022 | 36358791 | PubTator, text mining | PubMed |
| Metabolic Pathways, Enzymes, and Metabolites: Opportunities in Cancer Therapy. | Cancers (Basel) | 2022 | 36358687 | PubTator, text mining | PubMed |
| Evaluation of pharmaceutically compounded oral caffeine on the impact of medication adherence and risk of readmission among preterm neonates: A single-center quasi-experimental study. | PLoS One | 2022 | 36350877 | PubTator, text mining | PubMed |
| MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway. | Oncotarget | 2022 | 36342456 | PubTator, text mining | PubMed |
| Natural products targeting glycolytic signaling pathways-an updated review on anti-cancer therapy. | Front Pharmacol | 2022 | 36339566 | PubTator, text mining | PubMed |
| Combining bulk RNA-sequencing and single-cell RNA-sequencing data to reveal the immune microenvironment and metabolic pattern of osteosarcoma. | Front Genet | 2022 | 36338972 | PubTator, text mining | PubMed |
| Blocking MG53S255 Phosphorylation Protects Diabetic Heart From Ischemic Injury. | Circ Res | 2022 | 36337049 | PubTator, text mining | PubMed |
| The contribution of common and rare genetic variants to variation in metabolic traits in 288,137 East Asians. | Nat Commun | 2022 | 36333282 | PubTator, text mining | PubMed |
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
| Warburg effect in colorectal cancer: the emerging roles in tumor microenvironment and therapeutic implications. | J Hematol Oncol | 2022 | 36319992 | PubTator, text mining | PubMed |
| Risk of advanced fibrosis in first-degree relatives of patients with nonalcoholic fatty liver disease. | J Clin Invest | 2022 | 36317632 | PubTator, text mining | PubMed |
| Pyruvate kinase deficiency mimicking congenital dyserythropoietic anemia type I. | Turk J Pediatr | 2022 | 36305449 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5313/papers?page=20